| Year |
Citation |
Score |
| 2023 |
Searcy MB, Larsen RK, Stevens BT, Zhang Y, Jin H, Drummond CJ, Langdon CG, Gadek KE, Vuong K, Reed KB, Garcia MR, Xu B, Kimbrough DW, Adkins GE, Djekidel N, ... ... Hatley ME, et al. PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors. Nature Communications. 14: 7291. PMID 37968277 DOI: 10.1038/s41467-023-43044-1 |
0.74 |
|
| 2022 |
Singh S, Abu-Zaid A, Jin H, Fang J, Wu Q, Wang T, Feng H, Quarni W, Shao Y, Maxham L, Abdolvahabi A, Yun MK, Vaithiyalingam S, Tan H, Bowling J, ... ... Hatley M, et al. Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma. Science Translational Medicine. 14: eabq2096. PMID 35857643 DOI: 10.1126/scitranslmed.abq2096 |
0.35 |
|
| 2022 |
Hanna JA, Langdon CG, Garcia MR, Benton A, Lanman NA, Finkelstein D, Rehg JE, Hatley ME. Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2-Cre mice. The Journal of Pathology. PMID 35066877 DOI: 10.1002/path.5873 |
0.737 |
|
| 2021 |
Langdon CG, Hatley ME. The perfect PTEN - transcriptional regulation by PTEN dictates sarcoma identity. Molecular & Cellular Oncology. 8: 2002120. PMID 35419479 DOI: 10.1080/23723556.2021.2002120 |
0.762 |
|
| 2021 |
Langdon CG, Gadek KE, Garcia MR, Evans MK, Reed KB, Bush M, Hanna JA, Drummond CJ, Maguire MC, Leavey PJ, Finkelstein D, Jin H, Schreiner PA, Rehg JE, Hatley ME. Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity. Nature Communications. 12: 5520. PMID 34535684 DOI: 10.1038/s41467-021-25829-4 |
0.677 |
|
| 2018 |
Drummond CJ, Hatley ME. A Case of mistaken identity: Rhabdomyosarcoma development from endothelial progenitor cells. Molecular & Cellular Oncology. 5: e1448246. PMID 30250910 DOI: 10.1080/23723556.2018.1448246 |
0.754 |
|
| 2018 |
Hanna JA, Garcia MR, Lardennois A, Leavey PJ, Maglic D, Fagnan A, Go JC, Roach J, Wang YD, Finkelstein D, Hatley ME. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Oncogene. PMID 29367756 DOI: 10.1038/s41388-017-0081-3 |
0.743 |
|
| 2018 |
Drummond CJ, Hanna JA, Garcia MR, Devine DJ, Heyrana AJ, Finkelstein D, Rehg JE, Hatley ME. Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. Cancer Cell. 33: 108-124.e5. PMID 29316425 DOI: 10.1016/J.Ccell.2017.12.001 |
0.753 |
|
| 2017 |
Hanna JA, Drummond CJ, Garcia MR, Go JC, Finkelstein D, Rehg JE, Hatley ME. Biallelic Dicer1 loss mediated by aP2-Cre drives angiosarcoma. Cancer Research. PMID 28916654 DOI: 10.1158/0008-5472.CAN-17-1262 |
0.757 |
|
| 2013 |
Chen X, Stewart E, Shelat AA, Qu C, Bahrami A, Hatley M, Wu G, Bradley C, McEvoy J, Pappo A, Spunt S, Valentine MB, Valentine V, Krafcik F, Lang WH, et al. Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell. 24: 710-24. PMID 24332040 DOI: 10.1016/J.Ccr.2013.11.002 |
0.382 |
|
| 2012 |
Hatley ME, Tang W, Garcia MR, Finkelstein D, Millay DP, Liu N, Graff J, Galindo RL, Olson EN. A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. Cancer Cell. 22: 536-46. PMID 23079662 DOI: 10.1016/J.Ccr.2012.09.004 |
0.619 |
|
| 2010 |
Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 18: 282-93. PMID 20832755 DOI: 10.1016/J.Ccr.2010.08.013 |
0.386 |
|
| 2003 |
Hatley ME, Lockless SW, Gibson SK, Gilman AG, Ranganathan R. Allosteric determinants in guanine nucleotide-binding proteins. Proceedings of the National Academy of Sciences of the United States of America. 100: 14445-50. PMID 14623969 DOI: 10.1073/Pnas.1835919100 |
0.432 |
|
| 2002 |
Hatley ME, Gilman AG, Sunahara RK. Expression, purification, and assay of cytosolic (catalytic) domains of membrane-bound mammalian adenylyl cyclases. Methods in Enzymology. 345: 127-40. PMID 11665600 DOI: 10.1016/S0076-6879(02)45012-4 |
0.607 |
|
| Show low-probability matches. |